Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up - Top-Institutions - MDSpire

Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up

  • By

  • Kevin A. Huynh

  • Eva C. Coopmans

  • Amir H. Zamanipoor Najafabadi

  • Linda Dirven

  • Saskia M. Peerdeman

  • Nienke R. Biermasz

  • Marco J. T. Verstegen

  • Wouter R. van Furth

  • January 10, 2023

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Radiation Oncology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiation Oncology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Health Services Research

  • #4

    The Netherlands Cancer Institute (NKI)
    The Netherlands Cancer Institute (NKI)

    Amsterdam, N/A

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Epidemiology

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Health Economics

Original Source(s)

Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up

  • by Kevin A. Huynh, Eva C. Coopmans, Amir H. Zamanipoor Najafabadi, Linda Dirven, Saskia M. Peerdeman, Nienke R. Biermasz, Marco J. T. Verstegen, Wouter R. van Furth

  • January 10, 2023

Related Content

Psychological and cognitive outcomes in patients with unruptured intracranial aneurysms and aneurysmal subarachnoid haemorrhage: a multidimensional assessment

Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study

Risk prediction models for depression in older adults with cancer